Nearly 42,000 bottles of baby powder sold across the country have been recalled due to the risk they are contaminated with cancer-causing asbestos, according to the US Food and Drug Administration.

Dynacare baby powder that was distributed in 35 states, as well as sold online on Amazon, has been recalled over possible asbestos contamination. More than 1,000 cases of Dynacare Baby Powder have ...

The baby powder included in the latest recall from Dynacare is item number 4875, batch number B051, expiration date 2026/12/28 (located on the bottom of the bottle).

Baby powder does a solid job of interfering with these communications in multiple ways. Fine particles will absorb and neutralize pheromones, erasing the paths created by the worker ants.

In 2023, a jury decided J&J must pay $18.8 million to a California man who developed mesothelioma after using J&J’s baby powder regularly since he was a child.

If you have the recalled baby powder, you can contact Dynarex Corporation at 888-396-2739 or 845-365-8200 between 8:30 a.m. and 5 p.m. ET, or email the company at recall@dynarex.com.

A type of baby powder distributed in 35 states and sold online through Amazon is being recalled due to potential contamination with asbestos.. The Dynarex Corporation said Monday that its earlier ...

The initial recall involved 62 cases of Dynacare baby powder, with each case holding 24- and 14-ounce bottles.. Manufactured from Oct. 31, 2023 through Feb. 1, 2024, the recalled powder's ...

Talc is not banned in the U.S., but today, many baby powder brands instead use cornstarch, which is used as an absorbent in cosmetics. While cornstarch is likely a safer choice than talc, some ...

Companies that make talc-based powder have faced thousands of lawsuits about their products. Johnson & Johnson stopped selling talc-based baby powder in 2020. The company has denied any cancer link.

New research published this week lends credence to the more than 50,000 lawsuits against Johnson & Johnson that allege its talc-based baby powder caused ovarian cancer.. The analysis, released ...